US Stock MarketDetailed Quotes

PBLA Panbela Therapeutics

Watchlist

0.349
-0.008-2.34%

15min DelayClose Nov 22 16:00 ET

1.70MMarket Cap-10P/E (TTM)

Panbela Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Total revenue

Operating revenue

--0

Cost of revenue

Gross profit

Operating expense

-8.68%7.17M

37.88%8.1M

38.40%6.73M

-24.77%25.65M

35.96%7.04M

116.56%7.85M

-72.39%5.88M

21.38%4.86M

240.59%34.09M

56.48%5.18M

Selling and administrative expenses

0.54%1.11M

-32.68%1.11M

-10.95%1.2M

-16.73%5.03M

-45.07%931K

-14.45%1.11M

30.60%1.64M

-24.72%1.35M

31.76%6.04M

33.36%1.7M

-General and administrative expense

0.54%1.11M

-32.68%1.11M

-10.95%1.2M

-16.73%5.03M

-45.07%931K

-14.45%1.11M

30.60%1.64M

-24.72%1.35M

31.76%6.04M

33.36%1.7M

Research and development costs

-10.19%6.05M

65.26%7M

57.41%5.52M

-26.51%20.61M

75.36%6.11M

189.35%6.74M

-78.86%4.23M

58.88%3.51M

417.22%28.05M

70.88%3.49M

Operating profit

8.68%-7.17M

-37.88%-8.1M

-38.40%-6.73M

24.77%-25.65M

-35.96%-7.04M

-116.56%-7.85M

72.39%-5.88M

-21.38%-4.86M

-240.59%-34.09M

-56.48%-5.18M

Net non-operating interest income expense

-1,909.09%-442K

-180.95%-59K

26.74%-63K

29.20%-194K

64.41%-63K

72.84%-22K

-50.00%-21K

-4,200.00%-86K

-2,390.91%-274K

-5,800.00%-177K

Non-operating interest income

--0

778.57%123K

125.00%9K

716.67%49K

2,350.00%49K

1,500.00%16K

1,300.00%14K

--4K

Non-operating interest expense

522.54%442K

-15.71%59K

-38.24%63K

10.07%317K

-60.22%72K

-18.39%71K

337.50%70K

3,300.00%102K

2,300.00%288K

5,933.33%181K

Other net income (expense)

2,316.67%435K

1,347.56%1.02M

-180.84%-469K

157.48%392K

0.49%614K

102.39%18K

90.33%-82K

-153.70%-167K

-13.29%-682K

6,688.89%611K

Special income (charges)

--0

--775K

----

--400K

--0

--400K

--0

----

--0

-Gain on sale of property,plant,equipment

--0

--775K

----

--400K

--0

--400K

--0

----

--0

Other non- operating income (expenses)

213.87%435K

402.44%248K

-180.84%-469K

98.83%-8K

0.49%614K

49.34%-382K

90.33%-82K

-153.70%-167K

-13.29%-682K

6,688.89%611K

Income before tax

8.64%-7.17M

-19.38%-7.14M

-41.95%-7.26M

27.39%-25.45M

-36.78%-6.49M

-76.09%-7.85M

73.00%-5.98M

-38.38%-5.11M

-229.94%-35.05M

-43.63%-4.75M

Income tax

-138K

-60.34%-186K

-58.33%-19K

66.07%-19K

-716.67%-147K

76.23%-116K

-105.15%-12K

Net income

8.42%-7.17M

-22.39%-7.14M

-39.25%-7.12M

27.68%-25.26M

-36.73%-6.47M

-77.90%-7.83M

73.64%-5.83M

-39.47%-5.11M

-244.68%-34.93M

-33.83%-4.74M

Net income continuous Operations

8.42%-7.17M

-22.39%-7.14M

-39.25%-7.12M

27.68%-25.26M

-36.73%-6.47M

-77.90%-7.83M

73.64%-5.83M

-39.47%-5.11M

-244.68%-34.93M

-33.83%-4.74M

Minority interest income

Net income attributable to the parent company

8.42%-7.17M

-22.39%-7.14M

-39.25%-7.12M

27.68%-25.26M

-36.73%-6.47M

-77.90%-7.83M

73.64%-5.83M

-39.47%-5.11M

-244.68%-34.93M

-33.83%-4.74M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

8.42%-7.17M

-22.39%-7.14M

-39.25%-7.12M

27.68%-25.26M

-36.73%-6.47M

-77.90%-7.83M

73.64%-5.83M

-39.47%-5.11M

-244.68%-34.93M

-33.83%-4.74M

Basic earnings per share

97.25%-1.48

99.08%-1.47

99.42%-2.28

98.42%-316.52

99.60%-13.4868

98.94%-53.74

99.38%-159.15

94.00%-392.76

-10.36%-19.97K

46.06%-3.41K

Diluted earnings per share

97.25%-1.48

99.08%-1.47

99.42%-2.28

98.42%-316.52

99.60%-13.4868

98.94%-53.74

99.38%-159.15

94.00%-392.76

-10.36%-19.97K

46.06%-3.41K

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Total revenue	0	0	0	0	0	0	0	0	0	0
Operating revenue	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Cost of revenue
Gross profit
Operating expense	-8.68%7.17M	37.88%8.1M	38.40%6.73M	-24.77%25.65M	35.96%7.04M	116.56%7.85M	-72.39%5.88M	21.38%4.86M	240.59%34.09M	56.48%5.18M
Selling and administrative expenses	0.54%1.11M	-32.68%1.11M	-10.95%1.2M	-16.73%5.03M	-45.07%931K	-14.45%1.11M	30.60%1.64M	-24.72%1.35M	31.76%6.04M	33.36%1.7M
-General and administrative expense	0.54%1.11M	-32.68%1.11M	-10.95%1.2M	-16.73%5.03M	-45.07%931K	-14.45%1.11M	30.60%1.64M	-24.72%1.35M	31.76%6.04M	33.36%1.7M
Research and development costs	-10.19%6.05M	65.26%7M	57.41%5.52M	-26.51%20.61M	75.36%6.11M	189.35%6.74M	-78.86%4.23M	58.88%3.51M	417.22%28.05M	70.88%3.49M
Operating profit	8.68%-7.17M	-37.88%-8.1M	-38.40%-6.73M	24.77%-25.65M	-35.96%-7.04M	-116.56%-7.85M	72.39%-5.88M	-21.38%-4.86M	-240.59%-34.09M	-56.48%-5.18M
Net non-operating interest income expense	-1,909.09%-442K	-180.95%-59K	26.74%-63K	29.20%-194K	64.41%-63K	72.84%-22K	-50.00%-21K	-4,200.00%-86K	-2,390.91%-274K	-5,800.00%-177K
Non-operating interest income	--0	--0	--0	778.57%123K	125.00%9K	716.67%49K	2,350.00%49K	1,500.00%16K	1,300.00%14K	--4K
Non-operating interest expense	522.54%442K	-15.71%59K	-38.24%63K	10.07%317K	-60.22%72K	-18.39%71K	337.50%70K	3,300.00%102K	2,300.00%288K	5,933.33%181K
Other net income (expense)	2,316.67%435K	1,347.56%1.02M	-180.84%-469K	157.48%392K	0.49%614K	102.39%18K	90.33%-82K	-153.70%-167K	-13.29%-682K	6,688.89%611K
Special income (charges)	--0	--775K	----	--400K	--0	--400K	--0	----	--0	--0
-Gain on sale of property,plant,equipment	--0	--775K	----	--400K	--0	--400K	--0	----	--0	--0
Other non- operating income (expenses)	213.87%435K	402.44%248K	-180.84%-469K	98.83%-8K	0.49%614K	49.34%-382K	90.33%-82K	-153.70%-167K	-13.29%-682K	6,688.89%611K
Income before tax	8.64%-7.17M	-19.38%-7.14M	-41.95%-7.26M	27.39%-25.45M	-36.78%-6.49M	-76.09%-7.85M	73.00%-5.98M	-38.38%-5.11M	-229.94%-35.05M	-43.63%-4.75M
Income tax	0	0	-138K	-60.34%-186K	-58.33%-19K	66.07%-19K	-716.67%-147K	0	76.23%-116K	-105.15%-12K
Net income	8.42%-7.17M	-22.39%-7.14M	-39.25%-7.12M	27.68%-25.26M	-36.73%-6.47M	-77.90%-7.83M	73.64%-5.83M	-39.47%-5.11M	-244.68%-34.93M	-33.83%-4.74M
Net income continuous Operations	8.42%-7.17M	-22.39%-7.14M	-39.25%-7.12M	27.68%-25.26M	-36.73%-6.47M	-77.90%-7.83M	73.64%-5.83M	-39.47%-5.11M	-244.68%-34.93M	-33.83%-4.74M
Minority interest income
Net income attributable to the parent company	8.42%-7.17M	-22.39%-7.14M	-39.25%-7.12M	27.68%-25.26M	-36.73%-6.47M	-77.90%-7.83M	73.64%-5.83M	-39.47%-5.11M	-244.68%-34.93M	-33.83%-4.74M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	8.42%-7.17M	-22.39%-7.14M	-39.25%-7.12M	27.68%-25.26M	-36.73%-6.47M	-77.90%-7.83M	73.64%-5.83M	-39.47%-5.11M	-244.68%-34.93M	-33.83%-4.74M
Basic earnings per share	97.25%-1.48	99.08%-1.47	99.42%-2.28	98.42%-316.52	99.60%-13.4868	98.94%-53.74	99.38%-159.15	94.00%-392.76	-10.36%-19.97K	46.06%-3.41K
Diluted earnings per share	97.25%-1.48	99.08%-1.47	99.42%-2.28	98.42%-316.52	99.60%-13.4868	98.94%-53.74	99.38%-159.15	94.00%-392.76	-10.36%-19.97K	46.06%-3.41K
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data